AUD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.97 Million AUD | -47.69% |
2022 | -2.78 Million USD | 16.67% |
2021 | -3.76 Million AUD | -5.37% |
2020 | -3.08 Million AUD | -7.91% |
2019 | -4.29 Million AUD | -49.48% |
2018 | -2.87 Million AUD | -246.49% |
2017 | -829.73 Thousand AUD | 69.34% |
2016 | -2.7 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.14 Million AUD | 0.0% |
2023 Q2 | -2.91 Million AUD | 0.0% |
2023 FY | - AUD | -47.69% |
2023 Q4 | -3.09 Million AUD | 0.0% |
2022 Q2 | -1.84 Million AUD | 0.0% |
2022 Q4 | -2.23 Million AUD | 0.0% |
2022 FY | - USD | 16.67% |
2021 FY | - AUD | -5.37% |
2021 Q4 | -2.79 Million AUD | 0.0% |
2021 Q2 | -2.09 Million AUD | 0.0% |
2020 Q4 | -2.6 Million AUD | 0.0% |
2020 FY | - AUD | -7.91% |
2020 Q2 | -1.99 Million AUD | 0.0% |
2019 FY | - AUD | -49.48% |
2019 Q4 | -2.36 Million AUD | 0.0% |
2019 Q2 | -1.93 Million AUD | 0.0% |
2018 Q4 | -1.02 Million AUD | 0.0% |
2018 FY | - AUD | -246.49% |
2018 Q2 | -944.52 Thousand AUD | 0.0% |
2018 Q1 | -944.52 Thousand AUD | 0.0% |
2017 FY | - AUD | 69.34% |
2017 Q4 | -944.52 Thousand AUD | 0.0% |
2016 FY | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
4DMedical Limited | -36.06 Million AUD | 88.987% |
Adherium Limited | -11.56 Million AUD | 65.653% |
Aroa Biosurgery Limited | -7.36 Million AUD | 46.032% |
Atomo Diagnostics Limited | -5.42 Million AUD | 26.762% |
Anteris Technologies Ltd | -66.9 Million AUD | 94.063% |
Control Bionics Limited | -5.15 Million AUD | 22.995% |
CardieX Limited | -6.71 Million AUD | 40.82% |
Compumedics Limited | 2.78 Million AUD | 242.419% |
Cochlear Limited | 579.5 Million AUD | 100.685% |
CleanSpace Holdings Limited | -3.49 Million AUD | -13.754% |
Cyclopharm Limited | -3.03 Million AUD | -30.88% |
EMVision Medical Devices Ltd | -2.09 Million AUD | -89.941% |
Nova Eye Medical Limited | -5.97 Million AUD | 33.566% |
Imricor Medical Systems, Inc. | -21.87 Million AUD | 81.838% |
ImpediMed Limited | -22.05 Million AUD | 81.987% |
InhaleRx Limited | -1.41 Million AUD | -180.961% |
LBT Innovations Limited | -4.04 Million AUD | 1.9% |
Micro-X Limited | -14.35 Million AUD | 72.322% |
Neurotech International Limited | -8.24 Million AUD | 51.819% |
OncoSil Medical Limited | -11.97 Million AUD | 66.834% |
PolyNovo Limited | 5.17 Million AUD | 176.829% |
Respiri Limited | -7.04 Million AUD | 43.658% |
SomnoMed Limited | -2.32 Million AUD | -70.576% |
Universal Biosensors, Inc. | -9.09 Million AUD | 56.305% |
Uscom Limited | -1.5 Million AUD | -163.171% |
Visioneering Technologies, Inc. | -4.91 Million AUD | 19.224% |